Clinical trials
Phase 2 Hemorrhage trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Terminated | 8 |
| Recruiting | 7 |
| Withdrawn | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jason Sperry | 2 |
| Northwell Health | 2 |
| Portola Pharmaceuticals | 2 |
| Westat | 2 |
| Advanced Circulatory Systems | 1 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| Corewell Health East | 1 |
| Daniel Nishijima, MD, MAS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 42 |
| Wounds and Injuries | 6 |
| Shock, Hemorrhagic | 3 |
| Thrombosis | 3 |
| Acute Kidney Injury | 2 |
| Cerebral Hemorrhage | 2 |
| Coronary Artery Disease | 2 |
| Heart Diseases | 2 |
| Myocardial Ischemia | 2 |
| Prostatic Neoplasms | 2 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.